跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sedoz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sedoz
Approved
STANDARD
Sedoz
Baxter Pharmaceuticals India Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5a936c87b227f079
Company
Baxter Pharmaceuticals India Private Limited
Type
Standard
Approval Details
Approval Id
5a936c87b227f079
Drug Approval Philippines Name
Sedoz
Product Name
Sedoz
Registration Number
DR-XY30768
Brand Name
Sedoz
Generic Name
Midazolam
Dosage Form
Solution for Injection (IM/IV)
Dosage Strength
1 mg/mL
Manufacturer
Baxter Pharmaceuticals India Private Limited
Importer
Claris Lifesciences Philippines, Inc.
Distributor
Macropharma Corporation
Company Detail Path
/organization/baxter-pharmaceuticals-india-private-limited
Issuance Date
25 March 2025
Expiry Date
23 May 2031
Pharmacologic Category
Anxiolytic/Hypnotic (Benzodiazepine Derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5a936c87b227f079
Type
Standard
Back to Philippines FDA Approvals